MAPT and Alzheimer disease: This is the first report documenting a patient with AD, subcortical hemorrhage, and cSS due to CAA, showing 18F-MK-6240 accumulation in cortical tau pathology, in addition to subcortical hemorrhage and cSS as off-target effects, without corresponding uptake in CMBs.